Search

everythinglearnresearchcommunity

for

Search:↓

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Finasteride may cause side effects; more research needed.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

Finasteride and dutasteride can harm male reproductive health, affecting sperm and causing sexual dysfunction.

Combining Minoxidil and finasteride is more effective for hair growth but may cause side effects.

Finasteride can cause sexual and psychological side effects, but these usually reverse after stopping the medication.

Young men's erectile dysfunction is linked to mental health issues and risky behaviors promoted by online communities, highlighting the need for better mental health support and healthy masculinity standards.

Post-finasteride syndrome is rare but serious and should be taken seriously.

Hair loss drugs may cause sexual issues and infertility in men.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Finasteride may cause mental and sexual side effects, with hand preference and sexual orientation possibly affecting severity.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

The Princeton III Consensus recommends assessing cardiovascular risk in men with erectile dysfunction and prioritizing heart health before treating ED, especially in those with potential heart disease.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Finasteride use linked to increased suicidality in patients under 45.